An innovative, low cost, much needed solution to the global isotope shortage in medical, semiconductors, and nuclear power
Monopoly-Breaking Technology in Critical Markets
Western governments mandate isotope supply independence, ASPI becomes sole alternative to Russia.
Market Positioning Across Megatrends
Medical, quantum, and nuclear sectors converge simultaneously, creating unprecedented demand surge.
Western Isotope Independence
Multi-billion defense contracts secure long-term revenue streams, validating strategic positioning.
Technology Execution Risk
Scaling failures delay commercial production, burning cash without revenue generation.
Regulatory and Environmental Compliance Burden
Nuclear regulators shut down operations, environmental lawsuits halt expansion plans.
Customer Concentration and Market Timing Risk
Quantum computing stalls, customers choose cheaper Russian isotopes despite sanctions.
CurationAI can make mistakes, this is not investment advice. Got feedback?